PES INCLUDED IN AHA/ASA STROKE GUIDELINE

News & Events

FEATURED STORY

Featured, Press Release

AHA/ASA 2026 Guideline Now Recognizes Pharyngeal Electrical Stimulation for Stroke Rehabilitation

In the News

Atlantic Health introduces Phagenyx®: Advanced therapy for post-stroke swallowing disorders

Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors

Phagenesis Successfully Closes a $42M Series D Financing Round Led by EQT Life Sciences and Sectoral Asset Management

AU Health Is the First Acute Care Center in the U.S. to Offer Breakthrough Dysphagia Treatment

Webinars

From Neuroplasticity to Recovery: The Science and Clinical Application of PES

Launching a Successful PES Program

Advancing Dysphagia Management: An Introduction to PES

Pioneering Dysphagia Rehabilitation With Pharyngeal Electrical Stimulation

Stories

November 1, 2024

Phagenesis CEO Hoskins on Helping Stroke Survivors Recover; How Distalmotion Will Target ASCs

August 15, 2023

Arizona Chef Able to Swallow Again Thanks to New Therapy Used to Treat Stroke Patients at Banner – University Medical Center Phoenix

Pharyngeal Electrical Stimulation Helps Critically Ill COVID-19 Patients With Dysphagia Recover Safely: A Case Report Using the Phagenyx PES System

Events

We’re hitting the road to share the latest clinical evidence, patient outcomes, and real-world impact of Phagenyx at leading stroke, neurology, and rehabilitation conferences across the globe. Meet the Phagenesis team, see a live demo, or attend our speaking sessions.

Upcoming Events

September 10-12, 2026 | Berlin, Germany

German Stroke Congress (DSG26)

October 19-23, 2026 | Leiden, Netherlands

European Society for Swallowing Disorders (ESSD) Annual Congress

October 20–23, 2026 | Seattle, WA

Neurocritical Care Society (NCS) Annual Meeting

November 14-16, 2026 | Sun Valley, ID

2026 Association of Neurovascular Clinicians (ANVC) Annual Conference

Load more

As Seen In

Press Releases

September 2, 2026

AHA/ASA 2026 Guideline Now Recognizes Pharyngeal Electrical Stimulation for Stroke Rehabilitation

Atlantic Health introduces Phagenyx®: Advanced therapy for post-stroke swallowing disorders

Phagenesis Appoints Stephen Oesterle, MD, to Board of Directors

September 1, 2024

Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing

Load more